Related Experiment Video
Updated: Jul 24, 2025
07:41
Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
5.9K
Reduction in olfactory dysfunction prevalence among patients with diabetes taking metformin
Varun Vohra1, Anirudh Saraswathula1, Vidyulata Kamath2
1Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
International Forum of Allergy & Rhinology
|July 7, 2023
Summary
Metformin may protect the sense of smell in diabetic patients. This common diabetes medication appears to reduce olfactory dysfunction, suggesting benefits beyond blood sugar control.
Area of Science:
- Endocrinology
- Neurology
- Ophthalmology
Background:
- Diabetic patients frequently experience olfactory dysfunction (OD).
- The mechanisms underlying OD in diabetes are not fully understood.
- Glycemic control is a primary focus in managing diabetic complications.
Purpose of the Study:
- To investigate the association between metformin use and olfactory dysfunction in patients with diabetes.
- To explore potential neuroprotective effects of metformin on olfactory function.
Main Methods:
- Retrospective analysis of patient data.
- Comparison of olfactory function metrics between metformin users and non-users.
- Statistical analysis to control for confounding factors.
Main Results:
- Metformin treatment was significantly associated with a lower prevalence of olfactory dysfunction.
- Patients on metformin showed better olfactory test scores compared to controls.
- This association persisted after adjusting for age, diabetes duration, and glycemic control.
Conclusions:
- Metformin use is linked to reduced olfactory dysfunction in diabetic individuals.
- Metformin may offer protective benefits for olfactory function independent of its glucose-lowering effects.
- Further research is warranted to elucidate the direct mechanisms of metformin on olfactory pathways.
Related Concept Videos
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
238
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
238
01:15Diabetes: Symptoms, Diagnosis, and Complications
603
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
603
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
208
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
208
01:36Carbohydrate Metabolism
11.3K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.3K
01:22Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
01:23Dipeptidyl Peptidase 4 Inhibitors
214
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
214